IKNA - Financial Reports List - Ikena Oncology, Inc. - IntrinsicAlpha

Ikena Oncology, Inc. IKNA

Healthcare - Biotechnology - NASDAQ - US

$ 1.22

2.7 %

$ 49.1 M

Market Cap

-1.12

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	53.18%	42.87%
Annual Report	FY	10-K	2024-12-31	0.00%	27.77%	21.80%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	40.99%	36.38%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	19.78%	18.12%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-13.55%	-0.83%
Quarterly Report	Q4	8-K	2023-12-31	-87.91%	-49.00%	-44.95%
Annual Report	FY	10-K	2023-12-31	-41.35%	-2.31%	-6.36%
Quarterly Report	Q3	8-K	2023-09-30	-81.49%	-3.23%	-9.10%
Quarterly Report	Q2	8-K	2023-06-30	424.61%	14.56%	11.75%
Quarterly Report	Q1	8-K	2023-03-31	57.00%	14.94%	8.53%

1